<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30072194</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>03</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1938-0666</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Jun</Month>                        <Day>30</Day>                    </PubDate>                </JournalIssue>                <Title>Clinical breast cancer</Title>                <ISOAbbreviation>Clin. Breast Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Analysis of Efficacy and Accuracy of 2 Vacuum-Assisted Breast Biopsy Devices: Mammotome and Elite.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">S1526-8209(18)30347-1</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clbc.2018.06.014</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Ultrasound-guided vacuum-assisted breast biopsy (US-VABB) has recently replaced surgical biopsy as a result of its high diagnostic accuracy and low patient discomfort, and at present it relies mainly on 2 devices, Mammotome and, more recently, Mammotome Elite (Elite). Our purpose was to compare the efficacy of these 2 bioptical devices.</AbstractText>                <AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">We performed US-VABB on 195 patients with Mammotome 8G or 11G in 130 patients and Elite 13G in 65 patients. Of these 195 patients, 95 were submitted to surgery for lumpectomy or mastectomy in case of malignant lesions or of lesions of uncertain malignant potential (B5 and B3), while the remaining 100 were strictly monitored clinically and radiologically for 12 to 24 months.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Both the devices showed high absolute sensitivity (96.2% for Mammotome and 83.3% for Elite), complete sensitivity (98.1% for Mammotome and 90.0% for Elite), specificity (92.3% for Mammotome and 94.3% for Elite), and diagnostic accuracy (99.1% for Mammotome and 95% for Elite), thus fulfilling criteria suggested by the European guidelines. Total underestimation rate seemed to be higher in the Elite cohort (14.2%) than in the Mammotome cohort (3.4%) (P = .02). However, none of the patients with a benign diagnosis (B2) presented any event during the follow-up period.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">US-VABB is an accurate method for sampling breast lesions. Our study did not show large, statistically significant differences in diagnostic accuracy between the Elite and Mammotome systems, except for a slight increase in diagnostic underestimation of benign pathologies when using the Elite.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Bozzini</LastName>                    <ForeName>Anna</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Imaging Unit, European Institute of Oncology, Milan, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cassano</LastName>                    <ForeName>Enrico</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Imaging Unit, European Institute of Oncology, Milan, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Raciti</LastName>                    <ForeName>Dario</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Imaging Unit, European Institute of Oncology, Milan, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Disalvatore</LastName>                    <ForeName>Davide</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>IFOM, The FIRC Institute for Molecular Oncology Foundation, Milan, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pala</LastName>                    <ForeName>Oriana</ForeName>                    <Initials>O</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Pathology, European Institute of Oncology, Milan, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Vingiani</LastName>                    <ForeName>Andrea</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Pathology, European Institute of Oncology, Milan, Italy. Electronic address: andrea.vingiani@ieo.it.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Renne</LastName>                    <ForeName>Giuseppe</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Uropathology and Intraoperative Consultation, European Institute of Oncology, Milan, Italy.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>06</Month>                <Day>30</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Clin Breast Cancer</MedlineTA>            <NlmUniqueID>100898731</NlmUniqueID>            <ISSNLinking>1526-8209</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Diagnostic accuracy</Keyword>            <Keyword MajorTopicYN="N">Diagnostic devices</Keyword>            <Keyword MajorTopicYN="N">Minimally invasive diagnosis</Keyword>            <Keyword MajorTopicYN="N">Ultrasound</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>06</Month>                <Day>25</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>25</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30072194</ArticleId>            <ArticleId IdType="pii">S1526-8209(18)30347-1</ArticleId>            <ArticleId IdType="doi">10.1016/j.clbc.2018.06.014</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>